Le Lézard
Classified in: Health, Science and technology
Subject: TDS

3D-Models for Drug Testing: Organoids & Tissue Chips 2022 - 2 Day Conference in Washington, United States on September 13-14th, 2022


DUBLIN, June 29, 2022 /PRNewswire/ -- The "3D-Models for Drug Testing: Organoids & Tissue Chips 2022" conference has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The conference is held co-located and concurrently with the SelectBIO Extracellular Vesicles 2022 Conference. All attendees receive full access to both tracks and the networking opportunities during the Food & Beverage events.

This 3D-Models: Organoids and Tissue Chips 2022 Conference focuses on the emerging tools for the ex vivo recapitulation of organ systems on board microfluidic chips and their utility for modeling physiological and disease processes in a controlled environment.

Additionally, technologies and tools for fabricating such systems ex vivo including organoids and tissue chips will be addressed during the conference.

There is a co-located exhibition with companies from around the world exhibiting on-site in person at the conference -- the focus therefore is on presentations from academic and industry speakers and exhibits by the companies offering tools, technologies, and services to the field.

Agenda:

 Speakers:

Conference Chair

Keynote Speakers

For more information about this conference visit https://www.researchandmarkets.com/r/v8l2dv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg



SOURCE Research and Markets


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: